- Home
- POAI vs FCAP Comparison
POAI vs FCAP Comparison
Compare POAI & FCAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAI
- FCAP
- Stock Information
- Founded
- POAI 2002
- FCAP 1891
- Country
- POAI United States
- FCAP United States
- Employees
- POAI 35
- FCAP N/A
- Industry
- POAI Industrial Specialties
- FCAP Savings Institutions
- Sector
- POAI Health Care
- FCAP Finance
- Exchange
- POAI Nasdaq
- FCAP Nasdaq
- Market Cap
- POAI 9.9M
- FCAP N/A
- IPO Year
- POAI N/A
- FCAP 1999
- Fundamental
- Price
- POAI $1.30
- FCAP $38.02
- Analyst Decision
- POAI Hold
- FCAP
- Analyst Count
- POAI 1
- FCAP 0
- Target Price
- POAI N/A
- FCAP N/A
- AVG Volume (30 Days)
- POAI 8.1M
- FCAP 4.3K
- Earning Date
- POAI 05-13-2025
- FCAP 04-25-2025
- Dividend Yield
- POAI N/A
- FCAP 3.07%
- EPS Growth
- POAI N/A
- FCAP N/A
- EPS
- POAI N/A
- FCAP 3.57
- Revenue
- POAI $1,623,817.00
- FCAP $41,997,000.00
- Revenue This Year
- POAI $486.27
- FCAP N/A
- Revenue Next Year
- POAI $65.50
- FCAP N/A
- P/E Ratio
- POAI N/A
- FCAP $10.72
- Revenue Growth
- POAI N/A
- FCAP 2.23
- 52 Week Low
- POAI $0.55
- FCAP $26.73
- 52 Week High
- POAI $3.06
- FCAP $39.40
- Technical
- Relative Strength Index (RSI)
- POAI 48.03
- FCAP 58.60
- Support Level
- POAI $1.26
- FCAP $37.64
- Resistance Level
- POAI $1.58
- FCAP $38.89
- Average True Range (ATR)
- POAI 0.21
- FCAP 0.49
- MACD
- POAI 0.01
- FCAP -0.16
- Stochastic Oscillator
- POAI 16.13
- FCAP 23.85
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.